Proteolysis-concentrating on chimeras (PROTACs) and molecular glue degraders (MGDs) are quite possibly the most maturely formulated TPD methods. In this particular critique, we focus on the two preclinical experiments and clinical trials to provide an extensive summary of the protection and clinical usefulness of PROTACs and MGDs in hematologic mal